Cargando…
Nonhematopoietic Variants of Erythropoietin in Ischemic Stroke: Need for Step-Wise Proof-of-Concept Studies
Neuroprotective, but not hematopoietic, variants of erythropoietin (EPO), such as Neuro-EPO, are promising candidates for treatment in the acute and subacute stroke phase. Characterized by its low sialic acid content and therefore exhibiting a very short plasma half-life, Neuro-EPO can probably not...
Autor principal: | Hermann, Dirk M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763796/ https://www.ncbi.nlm.nih.gov/pubmed/21103797 http://dx.doi.org/10.1100/tsw.2010.226 |
Ejemplares similares
-
Enhancing the Delivery of Erythropoietin and Its Variants into the Ischemic Brain
por: Hermann, Dirk M.
Publicado: (2009) -
Mesenchymal Stem Cell Therapy in Nonhematopoietic Diseases
por: de Carvalho, Katherine Athayde Teixeira, et al.
Publicado: (2015) -
Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress
por: Castillo, C., et al.
Publicado: (2017) -
Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues
Publicado: (1981) -
Nonhematopoietic IRAK1 drives arthritis via neutrophil chemoattractants
por: Hoyler, Thomas, et al.
Publicado: (2022)